Navigation Links
Dedication Ceremony Held for Louisiana Cancer Research Center in New Orleans

New Orleans, LA (PRWEB) October 23, 2013

The Louisiana Cancer Research Center (LCRC) held a ceremony today to officially dedicate its new 10-story, 180,000-square-foot building located at 1700 Tulane Avenue in downtown New Orleans. The state-of-the-art research facility represents Louisiana’s commitment to eradicating cancer among its citizens. The new facility, along with the research and programs provided by the Louisiana Cancer Research Consortium, is recognized by the State of Louisiana as the beginning of what will be a progressive biomedical corridor emanating from New Orleans and spreading throughout the coastal, southeast United States.

The LCRC is a collaboration of Louisiana State University (LSU) Health Sciences Center-New Orleans, Tulane University Health Sciences Center, Xavier University of Louisiana and Ochsner Health System. It offers access to technologies, services and scientific consultation that enhances scientific interaction and productivity. It is located in what is fast-becoming the city’s new biomedical corridor, an area that also includes the New Orleans BioInnovation Center, the University Medical Center at New Orleans, which is currently under construction, and the new VA Medical Center (also under construction), a teaching and research medical complex that will serve both Tulane and LSU medical schools.

Today’s ceremony, which included a ceremonial ribbon cutting and tours of the building, was attended by State Senator John A. Alario, Jr. - District 8, State Representative Walt Leger, III - District 91, Mitch Landrieu, Mayor, City of New Orleans and Jacquelyn Brechtel Clarkson, City of New Orleans Council President. In addition to local dignitaries, LCRC board members, scientific and administrative leadership, staff, university partners, area cancer research supporters and cancer survivors were all recognized for their continued support and commitment to the LCRC.

“The new LCRC building stands as the physical embodiment of the Consortium’s work,” said Larry Hollier, MD, chairman of the LCRC Board of Directors and Chancellor, LSU Health Sciences Center-New Orleans. “While the individual university partners provide state-of-the-art technologies necessary to assist researchers in their work, it is through the Core equipment and services provided under this roof, that helps facilitate collaboration across the various research programs, thus creating a vital flow of information that benefits everyone.”

“The LCRC is one of the first completed projects among the many state-of-the-art medical facilities currently under construction in our city,” said Dr. L. Lee Hamm, vice-chairman of the LCRC Board of Directors and Senior Vice President and Dean, Tulane University School of Medicine. “It will pioneer breakthrough advances in detection, treatment and prevention of cancer while fostering economic development in downtown New Orleans and throughout our region.”

The Consortium, which began with founding partners LSU Health Sciences Center-New Orleans and Tulane Health Sciences Center, expanded with the addition of Xavier University of Louisiana and Ochsner Health System, which joined the LCRC in 2007 and 2010, respectively. Both play vital roles in enhancing the cancer research taking place at the Center. Xavier’s cancer research focuses on prostate and breast cancer programs, as well as examining health disparities, while Ochsner and its local researchers, physicians and neighborhood clinics enhance the efforts of the existing LCRC partners in developing a world-class coordinated cancer research and education resource for this region.

“With approximately 160 Louisianans dying of cancer each week, the research that is currently taking place in this new facility and at our partner institutions will help us reduce Louisiana’s cancer mortality rates, while eliminating health disparities and saving more lives,” said Dr. Norman Francis, LCRC Board Member and President, Xavier University of Louisiana.”

The new facility was designed as a physical work-space for the Consortium’s work as it seeks National Cancer Institute (NCI) designation as a comprehensive cancer center. The collaborative cancer research and education programs within help optimize discovery and development of innovative cancer therapies, leading to innovative clinical treatment programs.

“The LCRC has always been an ambitious enterprise, bringing together the best and the brightest cancer researchers for the benefit of the citizens of Louisiana,” said William Pinsky, MD, LCRC Board Member and Executive Vice-President and Chief Academic Officer for Ochsner Health System. “Our goal is to provide the infrastructure to support the clinical research programs of all LCRC partners.”

Groundbreaking on the new Louisiana Cancer Research Center building took place in 2009, with researchers and staff moving into the building earlier this year. Four floors of the building are dedicated to cancer research laboratories for its partners’ research programs. One floor houses a vivarium and LCRC’s administrative offices, with four floors (80,000 square feet) dedicated to parking. A final floor is reserved for clinical research and support services. The building design includes a two-story glass element, which includes a spacious lobby and conference center capable of seating 250 people for scientific meetings, as well as community events.

“Louisiana, and specifically New Orleans, is gaining momentum in the area of biosciences,” added Hollier. “With the official opening today of the Louisiana Cancer Research Center and the addition of the new hospitals opening soon, we know that New Orleans can and will become a destination for distinguished researchers and cancer patients from around the region and the world.”

For more information about the Louisiana Cancer Research Center, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dedication to the Medical Industry - The First International PEEK Meeting
2. Bunker Hill Community College Holds Biomedical Careers Graduation Ceremony
3. UE LifeSciences Launches Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries
4. Polaris Group Files New IND for ADI-PEG 20 in Breast Cancer
5. ResearchMoz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
6. Spanish researchers sequence non-infiltrating bladder cancer exome
7. Football-shaped particles bolster the bodys defense against cancer
8. Study suggests: Blood test can differentiate between benign lung nodules and early stage lung cancer
9. Pancreatic cancer patient survival significantly higher with nab-paclitaxel, says TGen-led study
10. MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
11. Ventana launches first fully automated IHC test to detect BRAF V600E mutation in a variety of cancers
Post Your Comments:
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... , ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, ... serve as Chief Operating Officer. , Having joined InSphero in November 2013 ... was promoted to Head of InSphero Diagnostics in 2014. There she has built ...
(Date:11/24/2015)... Capricor Therapeutics, Inc. (NASDAQ: ... development and commercialization of first-in-class therapeutics, today announced that ... scheduled to present at the 2015 Piper Jaffray Healthcare ... at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... , November 24, 2015 , ... a European healthcare fund ... companies will work closely together in identifying European breakthrough technologies ... need. The collaboration is underpinned by a significant investment by ... is the first investment by Bristol-Myers Squibb in a European ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):